Can Insertional Mutagenesis be Therapeutically Targeted?
Yes, there are emerging therapeutic strategies aimed at mitigating the effects of insertional mutagenesis. Gene editing technologies such as CRISPR-Cas9 have the potential to correct disrupted genes or remove harmful insertions. Additionally, understanding the mechanisms of insertional mutagenesis can lead to the development of antiviral therapies that prevent viral integration, thereby reducing the risk of related diseases.
